OR WAIT null SECS
Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.
Activation and expansion are essential for success in both autologous and allogeneic therapies.
Continuous manufacturing and a quality-by-design development approach are a natural fit.
May 03, 2022
Advances in therapeutic modalities and an increase in molecular complexity have led to the need for an evolution in drug delivery approaches over the years.
Ongoing advances in technology and modeling techniques are helping to align all the objectives of both drug manufacturers and patients.
Using more exacting analytical tools can give a clearer assessment of gene-editing outcomes.
Digital maintenance solutions can help visualize the value and key activities provided by the equipment vendor from inception to utilization.
May 02, 2022
Recent trends in dissolution testing have led to increased use of data integrity solutions and more biorelevant testing techniques.
Partnering with an experienced service provider can help companies unlock the commercial potential of new therapeutic approaches.
April 28, 2022
Thermo Fisher Scientific has expanded its state-of-the-art R&D facility in Hyderabad, India.
April 26, 2022
Johnson & Johnson has launched its next Satellite Center for Global Health Discovery at Holistic Drug Discovery and Development Centre, University of Cape Town.
April 21, 2022
The European Investment Bank has provided €15 million to fund coronavirus research at IRBM.
April 20, 2022
Otsuka Pharmaceutical and Osaka University have entered an exclusive license agreement on a new anti-tumor antibody.